HyperglycemiaDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Blood GlucoseDiabetes Mellitus, ExperimentalInsulinDiabetes ComplicationsGlucoseHypoglycemic AgentsStreptozocinHemoglobin A, GlycosylatedGlucose Tolerance TestIslets of LangerhansDiabetes, GestationalInsulin ResistanceHypoglycemiaInsulin-Secreting CellsHyperinsulinismFastingGlucagonDiabetic NephropathiesRisk FactorsGlucose IntoleranceC-PeptidePostprandial PeriodGlucose Clamp TechniqueObesityPregnancy in DiabeticsPrediabetic StateDiabetic RetinopathyDiabetic KetoacidosisTime FactorsDiabetic NeuropathiesGlucokinaseBody WeightGluconeogenesisDiabetic AngiopathiesGlycosuriaAlloxanPhlorhizinDisease Models, AnimalPancreasLiverBlood Glucose Self-MonitoringRats, Sprague-DawleyRats, ZuckerGlucagon-Like Peptide 1Diabetes InsipidusMetforminRats, WistarOxidative StressHyperglycemic Hyperosmolar Nonketotic ComaReference ValuesMice, Inbred NODGlycosylation End Products, AdvancedIslets of Langerhans TransplantationPrevalenceBody Mass IndexFructosamineAlbuminuriaMetabolic Syndrome XFatty Acids, NonesterifiedProspective StudiesCohort StudiesCardiovascular DiseasesHyperlipidemiasInsulin Infusion SystemsHyperglycinemia, NonketoticTreatment OutcomeBiological MarkersRats, Inbred BBChoreaMice, ObeseMice, Inbred C57BLProinsulinTriglyceridesCells, CulturedPregnancyEndothelium, VascularAcute DiseaseRetrospective StudiesDiabetic DietAcarboseSulfonylurea CompoundsGlucose Transporter Type 2HypertensionLipidsDose-Response Relationship, DrugCritical IllnessHomeostasisFollow-Up StudiesBlood PressureDiabetic CardiomyopathiesDipeptidyl-Peptidase IV InhibitorsCross-Sectional StudiesDyslipidemiasKidneyIncidenceInfusions, Intravenous